Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TCM for Bronchial Asthma
NCT02937207Phase 2Unknown
- Sponsor
- Shanghai University of Traditional Chinese Medicine
- Start
- Jul 2017
- Primary completion
- Dec 2020
- Modality
- HM (Herbal Medicine), Herbal Medicine, NPI (Non-Pharmacological Intervention)
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of Ke Chuan Liu Wei Granule, Chuanxiong Pingchuan Mixture, Xie Wu Capsule, Dan Ma Jia Tablet, Zhi Chuan Capsule and 1 more in asthma (8 arms), sponsored by Shanghai University of Traditional Chinese Medicine. Primary endpoint: Asthma control rate at 12 months. Status: unknown.
02
Drugs
Ke Chuan Liu Wei GranuleChuanxiong Pingchuan MixtureXie Wu CapsuleDan Ma Jia TabletZhi Chuan Capsule
03
Conditions
asthma
Beyond the preview
Go deeper on NCT02937207.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02937207.